Greg Behar, Recipharm CEO
Recipharm hits record revenue for 2024, eyes GLP-1 contracts for growth
Greg Behar’s shakeup of Recipharm is paying off in his first year as CEO.
The CDMO reported record-high revenues on Friday, and the company expects …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
